Skip to main content
. Author manuscript; available in PMC: 2019 Feb 1.
Published in final edited form as: Breast Cancer Res Treat. 2017 Nov 20;168(1):107–115. doi: 10.1007/s10549-017-4583-z

Fig. 1.

Fig. 1

Nestin staining by immunohistochemistry. Tumors with <1% cytoplasmic staining for nestin were scored as negative (a) whereas those ≥1% were scored as positive (b)